Skip to main content
. 2021 Jul 14;15:706786. doi: 10.3389/fnins.2021.706786

FIGURE 1.

FIGURE 1

rTMS ameliorated CPZ-induced cognitive impairment and demyelination in mice. (A) Schematic diagram displaying the time course of rTMS treatment in a CPZ-induced mouse model of demyelination. C57BL/6 mice were administered CPZ for 6 weeks to induce demyelination, and rTMS was administered for 1 week after the conclusion of CPZ administration. (B–D) In the Y-maze test, CPZ-treated mice showed impaired spatial working memory and spatial cognitive ability, which was restored by rTMS. (E,F) In the 3-chamber test, mice in the CPZ group showed reduced social interactions and weaker social memory. Mice in the CPZ + rTMS group performed better than those treated with CPZ alone. (G–I) Representative immunoblots and densitometry analysis of MBP in the hippocampus, PFC, and striatum in the sham, CPZ, and CPZ + rTMS groups. E, empty wire-cup; S1, subject 1; S2, subject 2.